Maimon Yossi (CIK 0001385115)

Latest company ownership

PLX - Protalix BioTherapeutics, Inc.

Role: CFO

Shares held

700,000

Last filed at

Sep 14, 2018

Confidence Score

50.0

2025Q4

Confidence Score History

2008Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Dec 14, 2015	Dec 15, 2015	Protalix BioTherapeutics, Inc.	CFO	Buy	85.0	+10,000	5.41%	✗	$7.8K
May 2, 2012	May 4, 2012	Protalix BioTherapeutics, Inc.	CFO	Sell	7.5	-125,964	-100.00%	✓	$898.1K
Oct 7, 2010	Oct 8, 2010	Protalix BioTherapeutics, Inc.	CFO	Sell	7.5	-77,769	-100.00%	✓	$752.5K
Sep 3, 2010	Sep 8, 2010	Protalix BioTherapeutics, Inc.	CFO	Sell	7.5	-70,000	-100.00%	✓	$565K
Oct 15, 2009	Oct 19, 2009	Protalix BioTherapeutics, Inc.	CFO	Sell	5.0	-167,698	-100.00%	✓	$1.6M
Jul 6, 2009	Jul 8, 2009	Protalix BioTherapeutics, Inc.	CFO	Sell	7.5	-62,217	-100.00%	✓	$315.8K
May 18, 2009	May 19, 2009	Protalix BioTherapeutics, Inc.	CFO	Sell	22.5	-40,348	-100.00%	✗	$159.2K
Mar 11, 2009	Mar 13, 2009	Protalix BioTherapeutics, Inc.	CFO	Sell	22.5	-66,500	-100.00%	✗	$147.3K
Feb 22, 2008	Feb 26, 2008	Protalix BioTherapeutics, Inc.	CFO	Sell	22.5	-59,476	-40.69%	✗	$189.5K